NW Natural Holdings Reports Fourth Quarter and Full Year 2021 Results
Initiates 2022 earnings guidance and increases long-term EPS growth rate target PORTLAND, Ore.–(BUSINESS WIRE)–Northwest Natural…
News
Corent Technology Announces New Partnership With Leading UK Cloud Service Provider, New Scaler
LONDON & ALISO VIEJO, Calif.–(BUSINESS WIRE)–#CorentTech–New Scaler and Corent Technology Inc. today announced their new…
Robin.io to Accelerate 5G and Edge deployment and management at MWC#2022
Meet Robin.io at Booth #2E41 in Hall 2, Fira Barcelona Gran Via, February 28 to…
Immunocore receives positive CHMP opinion for KIMMTRAK® (tebentafusp) for the treatment of unresectable or metastatic uveal melanoma
PRESS RELEASE Immunocore receives positive CHMP opinion for KIMMTRAK® (tebentafusp) for the treatment of unresectable…
ScreenPro Increases Market Share in Covid Testing
Toronto, Ontario–(Newsfile Corp. – February 25, 2022) – ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF)…
Valneva Receives Initial CHMP Assessment of its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
Saint Herblain (France), February 25, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a…
QUVIVIQ (daridorexant) recommended for approval in Europe as a new treatment for adults with insomnia disorder
Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the…
Baudax Bio Announces Pricing of $10.0 Million Public Offering
MALVERN, Pa., Feb. 24, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (the “Company” or “Baudax…
CORRECTING and REPLACING CANbridge Announces Approval of CAN108 for Rare Liver Disease, Alagille Syndrome, Under the Early and Pilot Implementation Policy in Boao Lecheng International Medical Tourism Pilot Zone
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Please replace the release dated February 24th, 2022, with the following…
Aquestive Therapeutics Announces FDA Clearance of Investigational New Drug Application (IND) for AQST-109 Epinephrine Oral Film
WARREN, N.J., Feb. 24, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…
Mitsubishi Electric to Acquire U.S.-based Computer Protection Technology
Aiming to strengthen uninterruptible-power-supply business in North America TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO: 6503) announced…
Portage Biotech Announces Financial Results and Provides Business Update for Third Quarter of 2022 Fiscal Year
Company working to accelerate lead clinical programs; expects multiple clinical readouts in 2022 WESTPORT, Conn.,…
Pliant Therapeutics Announces Positive DSMB Safety Review and Commencement of Enrollment of Phase 2a Trial of PLN-74809 at 320 mg Dose in Idiopathic Pulmonary Fibrosis
Recent independent Data Safety Monitoring Board (DSMB) review recommended the INTEGRIS-IPF Phase 2a trial continue…
Operational Highlights and Financial Results for the Period Ended December 31, 2021
Mesoblast Prepares for Resubmission of Biologics License Application Late-Stage Clinical Pipeline Late-Stage Clinical Pipeline NEW…
Jasper Therapeutics Announces JSP191 Phase 1b MDS/AML Late Breaking Data Presentation at the 2022 Transplantation & Cellular Therapy Tandem Meetings of ASTCT and CIBMTR
JSP191 is well tolerated with no treatment-related severe adverse events in 17 subjects with myelodysplastic…
Vericel Announces Appointment of Jonathan Siegal as Principal Accounting Officer
CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced…
Baudax Bio Announces Proposed Public Offering of Securities
MALVERN, Pa., Feb. 24, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (the “Company” or “Baudax…
Cellectis to Hold Fourth Quarter 2021 Earnings Call on Friday March 4, 2022 at 8:00AM EST
NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS),…
DBV Technologies to Report Full Year 2021 Financial Results and Business Updates on March 3, 2022
Montrouge, France, February 24, 2022 DBV Technologies to Report Full Year 2021 Financial Results and…
Atreca to Report Fourth Quarter 2021 Results and Host Year-End Conference Call on March 3, 2022
SAN CARLOS, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a…